Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Sales | 32 | 0 | 0 | 50 |
| Cost of Goods | 424 | N/A | N/A | N/A |
| Gross Profit | -392 | N/A | N/A | 50 |
| Operating Expenses | 4,314 | 28,753 | 4,028 | 3,454 |
| Operating Income | -4,282 | -28,753 | -4,028 | -3,404 |
| Interest Expense | 793 | 1,065 | 444 | 462 |
| Other Income | -9,375 | 5,081 | 65 | -4,010 |
| Pre-tax Income | -14,450 | -24,737 | -4,407 | -7,876 |
| Income Tax | -2,580 | 33 | N/A | -621 |
| Net Income Continuous | -11,870 | -24,770 | -4,407 | -7,255 |
| Minority Interests | -32 | -62 | -71 | -204 |
| Net Income | $-11,838 | $-24,708 | $-4,336 | $-7,051 |
| EPS Basic Total Ops | -0.38 | -2.30 | -0.07 | -0.10 |
| EPS Basic Continuous Ops | -0.38 | -2.30 | -0.07 | -0.10 |
| EPS Diluted Total Ops | -0.38 | -2.30 | -0.07 | -0.10 |
| EPS Diluted Continuous Ops | -0.38 | -2.30 | -0.07 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.72 | N/A | N/A |
| EBITDA(a) | $-3,137 | $-2,541 | $-2,908 | $-2,291 |